Investigation is ongoing to determine RD.Clinical trial information: JapicCTI-184188.Toshio ShimizuDepartment of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan;Kan YonemoriNational Cancer Center Hospital, Tokyo, Japan;Takafumi Koyama...